158 related articles for article (PubMed ID: 16143264)
1. Perturbation of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 results in differential outcomes in cardiac vs islet allograft survival.
Grazia TJ; Gill RG; Gelhaus HC; Doan AN; Sleater ML; Pietra BA
J Heart Lung Transplant; 2005 Sep; 24(9):1410-4. PubMed ID: 16143264
[TBL] [Abstract][Full Text] [Related]
2. Roles of CD4+ and CD8+ cells in islet allo- and xeno-graft rejection.
Gotoh M; Monden M; Yamamoto H; Kawai M; Ichikawa T; Mori T; Uenaka A; Nakayama E
Horm Metab Res Suppl; 1990; 25():173-6. PubMed ID: 1982441
[TBL] [Abstract][Full Text] [Related]
3. Anti-ICAM-1/LFA-1 monoclonal antibody therapy prevents graft rejection and IDDM recurrence in BB rat pancreas transplantation.
Uchikoshi F; Ito T; Kamiike W; Moriguchi A; Nozaki S; Ito A; Kuhara A; Miyata M; Matsuda H; Miyasaka M
Transplant Proc; 1995 Apr; 27(2):1527-8. PubMed ID: 7725399
[No Abstract] [Full Text] [Related]
4. Coronary atherosclerosis in transplanted mouse hearts. IV Effects of treatment with monoclonal antibodies to intercellular adhesion molecule-1 and leukocyte function-associated antigen-1.
Russell PS; Chase CM; Colvin RB
Transplantation; 1995 Oct; 60(7):724-9. PubMed ID: 7570984
[TBL] [Abstract][Full Text] [Related]
5. A single administration of LFA-1 antibody confers prolonged allograft survival.
Talento A; Nguyen M; Blake T; Sirotina A; Fioravanti C; Burkholder D; Gibson R; Sigal NH; Springer MS; Koo GC
Transplantation; 1993 Feb; 55(2):418-22. PubMed ID: 7679531
[TBL] [Abstract][Full Text] [Related]
6. Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1.
Isobe M; Yagita H; Okumura K; Ihara A
Science; 1992 Feb; 255(5048):1125-7. PubMed ID: 1347662
[TBL] [Abstract][Full Text] [Related]
7. In vivo effects of monoclonal antibody to ICAM-1 (CD54) in nonhuman primates with renal allografts.
Cosimi AB; Conti D; Delmonico FL; Preffer FI; Wee SL; Rothlein R; Faanes R; Colvin RB
J Immunol; 1990 Jun; 144(12):4604-12. PubMed ID: 1972162
[TBL] [Abstract][Full Text] [Related]
8. Suppression of corneal allograft rejection after penetrating keratoplasty by antibodies to ICAM-1 and LFA-1 in mice.
Yamagami S; Obata H; Tsuru T; Isobe M
Transplant Proc; 1995 Apr; 27(2):1899-900. PubMed ID: 7725542
[No Abstract] [Full Text] [Related]
9. Prolongation of rat islet allograft survival by treatment with monoclonal antibodies against VLA-4 and LFA-1.
Yang H; Issekutz TB; Wright JR
Transplantation; 1995 Jul; 60(1):71-6. PubMed ID: 7624946
[TBL] [Abstract][Full Text] [Related]
10. CD8+ T-cell removal reduces survival of minor antigen mismatched islet allografts (CBA-->C3H) in mice treated with anti-CD4 monoclonal antibody.
Koulmanda M; Mandel TE
Transplant Proc; 1992 Oct; 24(5):2297-8. PubMed ID: 1413065
[No Abstract] [Full Text] [Related]
11. Promotion of murine orthotopic corneal allograft survival by systemic administration of anti-CD4 monoclonal antibody.
He YG; Ross J; Niederkorn JY
Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2723-8. PubMed ID: 1680112
[TBL] [Abstract][Full Text] [Related]
12. Characterization of intercellular adhesion molecule-1 ectodomain (sICAM-1) as an inhibitor of lymphocyte function-associated molecule-1 interaction with ICAM-1.
Meyer DM; Dustin ML; Carron CP
J Immunol; 1995 Oct; 155(7):3578-84. PubMed ID: 7561056
[TBL] [Abstract][Full Text] [Related]
13. Antibodies against leukocyte function-associated antigen-1 and against intercellular adhesion molecule-1 together suppress the progression of experimental allergic encephalomyelitis.
Kobayashi Y; Kawai K; Honda H; Tomida S; Niimi N; Tamatani T; Miyasaka M; Yoshikai Y
Cell Immunol; 1995 Sep; 164(2):295-305. PubMed ID: 7544693
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a monoclonal antibody recognizing an epitope designated as canine leukocyte-associated antigen.
Yang WC; Esquenazi V; Carreno M; Vallone T; Fuller L; Roth D; Nery J; Burke G; Miller J
Transplantation; 1994 Jul; 58(2):233-40. PubMed ID: 7518977
[TBL] [Abstract][Full Text] [Related]
15. Regulatory properties of LFA-1 alpha and beta chains in human T-lymphocyte activation.
van Noesel C; Miedema F; Brouwer M; de Rie MA; Aarden LA; van Lier RA
Nature; 1988 Jun; 333(6176):850-2. PubMed ID: 2968520
[TBL] [Abstract][Full Text] [Related]
16. Prevention of fetal bowel allograft rejection by combined treatment with anti-ICAM-1 and anti-LFA-1 antibodies.
Kato Y; Yamataka A; Yagita H; Bashuda H; Okumura K; Miyano T
J Pediatr Surg; 1995 Jul; 30(7):1093-7. PubMed ID: 7472940
[TBL] [Abstract][Full Text] [Related]
17. Late administration of monoclonal antibody to leukocyte function-antigen 1 abrogates incipient murine cerebral malaria.
Grau GE; Pointaire P; Piguet PF; Vesin C; Rosen H; Stamenkovic I; Takei F; Vassalli P
Eur J Immunol; 1991 Sep; 21(9):2265-7. PubMed ID: 1679717
[TBL] [Abstract][Full Text] [Related]
18. Induction of T-cell hyporesponsiveness by intrahepatic modulation of donor antigen-presenting cells.
Chung SW; Gorczynski RM; Dziadkowiec I; Levy GA
Immunology; 1995 Aug; 85(4):582-90. PubMed ID: 7558153
[TBL] [Abstract][Full Text] [Related]
19. Late treatment with anti-LFA-1 (CD11a) antibody prevents cerebral malaria in a mouse model.
Falanga PB; Butcher EC
Eur J Immunol; 1991 Sep; 21(9):2259-63. PubMed ID: 1679716
[TBL] [Abstract][Full Text] [Related]
20. Immunologic characterization of murine cardiac allograft recipients with long-term graft survival due to anti-VCAM-1 or anti-CD4 monoclonal antibody therapy.
Orosz CG; Bergese SD; Huang EH; Vanbuskirk AM
Transplant Proc; 1995 Feb; 27(1):387-8. PubMed ID: 7533414
[No Abstract] [Full Text] [Related]
[Next] [New Search]
